Literature DB >> 25372431

Subarachnoid hemorrhage-negative Terson syndrome after balloon-assisted coil embolization in a patient with underlying antiphospholipid antibody syndrome.

Vikas Gupta1, Anton M Kolomeyer, Neelakshi Bhagat, Roger E Turbin, Charles J Prestigiacomo, Chirag D Gandhi.   

Abstract

PURPOSE: To report subarachnoid hemorrhage-negative Terson syndrome after coil embolization of an unruptured intracranial aneurysm in a patient with underlying antiphospholipid syndrome.
METHODS: Retrospective case report. A 48-year-old woman with underlying antiphospholipid syndrome.
RESULTS: Our patient underwent balloon-assisted coil embolization of an unruptured right internal carotid artery aneurysm. There was herniation of the second coil requiring coil retrieval with subsequent nonflow limiting herniation of the first coil left in situ on anticoagulation. In the immediate postprocedure period, she developed preretinal, intraretinal, and vitreous hemorrhages requiring temporary withholding of anticoagulation therapy with careful resumption. Visual acuity was counting fingers and there was an afferent pupillary defect. Two week after discharge, the patient underwent a pars plana vitrectomy for dense breakthrough vitreous hemorrhage. Four weeks after pars plana vitrectomy, her visual acuity was 20/400.
CONCLUSION: Terson syndrome should be considered in a patient with visual symptoms after not only aneurysmal subarachnoid hemorrhage but also non-subarachnoid hemorrhage elective aneurysm coiling as demonstrated by our case.

Entities:  

Mesh:

Year:  2014        PMID: 25372431     DOI: 10.1097/ICB.0000000000000033

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  1 in total

1.  Subarachnoid hemorrhage-negative Terson syndrome after intracranial artery treatment with a flow diverter device.

Authors:  Takanori Matsuoka; Satoshi Matsuda; Seiyo Harino; Miho Kumoi; Eri Tachibana; Junko Yokoyama; Chieko Tsujino; Kumiko Kazuo; Yasumasa Otori
Journal:  Am J Ophthalmol Case Rep       Date:  2020-10-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.